No racial difference in allele frequencies of FCGR3A gene F158V polymorphisms in diffuse large B-cell lymphoma

被引：2
|
作者：
Hirakawa, Tsuneaki
Yamaguchi, Hiroki [1 ]
Mitamura, Yoshio [2 ]
Kosaka, Fumiko
Dan, Kazuo
Inokuchi, Koiti
机构：
[1] Nippon Med Sch, Dept Internal Med, Div Hematol, Bunkyo Ku, Tokyo 1138603, Japan
[2] Sekino Clin Pharmacol Clin, Dept Internal Med, Tokyo, Japan
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2011年 / 86卷 / 02期
关键词：
FC-GAMMA-RIIIA; NON-HODGKINS-LYMPHOMA; V/F POLYMORPHISM; PREDICT RESPONSE; RITUXIMAB; CHOP;
D O I：
10.1111/j.1600-0609.2010.01554.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：180 / 181
页数：2
相关论文
共 50 条
  • [11] A comprehensive overview of FCGR3A gene variability by full-length gene sequencing including the identification of V158F polymorphism
    Mahaweni, Niken M.
    Olieslagers, Timo I.
    Rivas, Ivan Olivares
    Molenbroeck, Stefan J. J.
    Groeneweg, Mathijs
    Bos, Gerard M. J.
    Tilanus, Marcel G. J.
    Voorter, Christina E. M.
    Wieten, Lotte
    SCIENTIFIC REPORTS, 2018, 8
  • [12] DNA repair gene XRCC1 polymorphisms and haplotypes in diffuse large B-cell lymphoma in a Korean population
    Kim, In-Suk
    Kim, Dong Chul
    Kim, Hoon-Gu
    Eom, Hyeon-Seok
    Kong, Sun-Young
    Shin, Ho-Jin
    Hwang, Sang-Hyun
    Lee, Eun-Yup
    Kim, Sunjoo
    Lee, Gyeong-Won
    CANCER GENETICS AND CYTOGENETICS, 2010, 196 (01) : 31 - 37
  • [13] FCGR2C genotyping by pyrosequencing reveals linkage disequilibrium with FCGR3A V158F and FCGR2A H131R polymorphisms in a Caucasian population
    Lejeune, Julien
    Piegu, Benoit
    Gouilleux-Gruart, Valerie
    Ohresser, Marc
    Watier, Herve
    Thibault, Gilles
    MABS, 2012, 4 (06) : 784 - 787
  • [14] Clinical and Pathologic Correlation of Increased MYC Gene Copy Number in Diffuse Large B-Cell Lymphoma
    Haws, Bryn T.
    Cui, Wei
    Persons, Diane L.
    Zhang, Da
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (12) : 679 - 683
  • [15] Genetic polymorphisms of STAT3 correlated with prognosis in diffuse large B-cell lymphoma patients treated with rituximab
    Hu, Yunfei
    Ding, Ning
    Jin, Xuan
    Feng, Lixia
    Ping, Lingyan
    Song, Yuqin
    Zhu, Jun
    CANCER CELL INTERNATIONAL, 2014, 14
  • [16] Racial Differences in the Presentation and Outcomes of Diffuse Large B-Cell Lymphoma in the United States
    Shenoy, Pareen J.
    Malik, Neha
    Nooka, Ajay
    Sinha, Rajni
    Ward, Kevin C.
    Brawley, Otis W.
    Lipscomb, Joseph
    Flowers, Christopher R.
    CANCER, 2011, 117 (11) : 2530 - 2540
  • [17] Diffuse large B-cell lymphoma with MYC gene rearrangements Current perspective on treatment of diffuse large B-cell lymphoma with MYC gene rearrangements; case series and review of the literature
    de Jonge, A. V.
    Roosma, T. J. A.
    Houtenbos, I.
    Vasmel, W. L. E.
    van de Hem, K.
    de Boer, J. P.
    van Maanen, T.
    Lindauer-van der Werf, G.
    Beeker, A.
    Timmers, G. J.
    Schaar, C. G.
    Soesan, M.
    Poddighe, P. J.
    de Jong, D.
    Chamuleau, M. E. D.
    EUROPEAN JOURNAL OF CANCER, 2016, 55 : 140 - 146
  • [18] Polymorphisms in the 3′-untranslated region of the CDH1 gene are a risk factor for primary gastric diffuse large B-cell lymphoma
    Jacobs, Gunnar
    Hellmig, Stephan
    Huse, Klaus
    Titz, Andrea
    Franke, Andre
    Kwiatkowski, Ruta
    Ott, Stephan
    Kosmahl, Markus
    Fischbach, Wolfgang
    Lucius, Ralph
    Klapper, Wolfram
    Foelsch, Ulrich R.
    Hampe, Jochen
    Schreiber, Stefan
    Rosenstiel, Philip
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (07): : 987 - 995
  • [19] Diffuse large B-cell lymphoma with low 18F-fluorodeoxyglucose avidity features silent B-cell receptor signaling
    Sheng, Dong
    Li, Ting
    Wang, Wei-Ge
    Li, Meng-Jiao
    Jiang, Kai-Long
    Gao, An-Hui
    Li, Jia
    Zhou, Xiao-Yan
    Li, Xiao-Qiu
    LEUKEMIA & LYMPHOMA, 2020, 61 (06) : 1364 - 1371
  • [20] Bcl-2 gene expression as a predictor of outcome in diffuse large B-cell lymphoma
    Shivakumar, Latha
    Armitage, James O.
    CLINICAL LYMPHOMA & MYELOMA, 2006, 6 (06) : 455 - 457
12345